Uses and safety profile of ciclosporin in ophthalmology

Abstract

Ciclosporin is a calcineurin inhibitor that acts by primarily inhibiting the action of T cells. Clinical trials in the early 1980s demonstrated that systemic ciclosporin was a promising steroid-sparing agent and was also effective in patients who are refractory to treatment with corticosteroids. However, recent years have witnessed the emergence of safer immunosuppressive agents due to the poor side-effect profile of systemic ciclosporin. Topical ciclosporin, however, has a much improved safety profile and is still used to treat a variety of ocular surface disorders including dry eye syndrome, vernal and atopic keratoconjunctivitis, severe blepharitis and high-risk corneal graft patients. This article reviews the uses and safety profile of systemic and topical ciclosporin in ophthalmology, as well as discussing alternative therapeutic agents available.

Keywords::

• atopic keratoconjunctivitis
• corneal graft
• dry eye
• methotrexate
• mycophenolate mofetil
• penetrating keratoplasty
• safety profile
• scleritis
• systemic ciclosporin
• tacrolimus
• topical ciclosporin
• uveitis
• vernal keratoconjunctivitis